EUVIMEDEUVIMED entdecken
Crossref

Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features

Jacob R Bledsoe, Judith A Ferry, Jingwei Li, Aaron Sassoon, Miekan A Stonhill, Bradford Siegele, Xiayuan Liang, Justin Dalton, Mark C Mochel, Yana Ivashkevich, Vandita Johari, Sam Sadigh und 14 weitere

Modern Pathology · 2026-07 · 39 (7) · 101015

DOI: 10.1016/j.modpat.2026.101015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-07. Verfasst von Jacob R Bledsoe und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham & Women's Hospit…. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, SMARCB1 Protein, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Boston Children's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) rarely occurs in pediatric and young adult populations, where little is known about its clinicopathologic and molecular features. We characterized 16 cases of PTCL, NOS diagnosed in patients ≤21 years old. Seven (44%) cases demonstrated SMARCB1/INI1 loss by immunohistochemistry and SMARCB1/INI1 alterations by next-generation sequencing, including biallelic SMARCB1/INI1 deletion (n = 4), stop codon variant with 1-copy deletion (n = 1) or copy-neutral loss-of-heterozygosity (n = 1), and frameshift variant (n = 1). One case demonstrated biallelic SMARCE1 alterations (a nonsense variant and copy-neutral loss-of-heterozygosity), which, to our knowledge, has not been previously described in a hematopoietic neoplasm. The SWI/SNF-intact group harbored pathogenic TET2, PTEN, EZH2, or TP53 variants. CDKN2A deletions were present in 3 of 7 SWI/SNF-deficient and 0 of 4 SWI/SNF-intact cases. Chromosome 22q11.2 alterations were present on karyotype in 2 of 3 SMARCB1/INI1-deficient cases. SWI/SNF deficiency was associated with intermediate-to-large cell cytomorphology, frequent mitotic (88%; P = .041) and apoptotic (88%) activity, Reed-Sternberg-like cells (63%), necrosis (50%), and fibrosis (50%). All cases expressed CD45 and CD43 at initial diagnosis. SWI/SNF-deficient cases predominantly demonstrated a CD4+/CD8-, TCRab, and PTCL-GATA3 phenotype, whereas SWI/SNF-intact cases predominantly demonstrated a CD8+/CD4-, TCRgd, and PTCL-TBX21 phenotype. A PTCL-TBX21 phenotype was more common in SWI/SNF-intact than in SWI/SNF-deficient cases (P = .041). Cytotoxic markers were expressed in 71% of SWI/SNF-deficient and 88% of SWI/SNF-intact cases. Decreased or absent CD3 expression characterized 88% of SWI/SNF-deficient and 13% of SWI/SNF-intact cases (P = .01). Moreover, 63% of SWI/SNF-deficient cases demonstrated decreased or absent expression of ≥3 pan-T-cell antigens, compared with 13% of SWI/SNF-intact cases. Treatment was heterogeneous. Primary treatment failure or relapse occurred in 4 of 8 SWI/SNF-deficient and 4 of 7 SWI/SNF-intact cases. The median overall survival and event-free survival were 48.7 and 47.5 months for the SWI/SNF-deficient group, and 16.4 and 8.9 months for the SWI/SNF-intact group (P = nonsignificant). Death due to disease or therapy-related complications occurred in 4 of 8 (50%) cases in the SWI/SNF-deficient group and 6 of 7 (86%) of cases in the SWI/SNF-intact group. Our findings expand the knowledge of the clinicopathologic and molecular features of pediatric PTCL and highlight SWI/SNF-deficient T-cell lymphoma as a biologically distinct type of PTCL that is associated with characteristic clinicopathologic features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralSMARCB1 ProteinBiomarkers, TumorHumansFemaleChildAdolescentMaleChild, PreschoolYoung AdultChromosomal Proteins, Non-HistonePhenotypeDNA-Binding ProteinsTranscription Factors

Stichwörter der Autor:innen

INI1SMARCB1SMARCE1childhoodlymphomapediatric

Substanzen

SMARCB1 ProteinSMARCB1 protein, humanBiomarkers, TumorChromosomal Proteins, Non-HistoneDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:…
  • Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Division of Pathology & Laboratory Medicine, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Department of Pathology, Rady Children's Health, Orange, California.
  • Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology, Children's Hospital Colorado, Aurora, Colorado.

Förderung

  • Boston Children's Hospital

Zitieren

APA

Bledsoe, J. R., Ferry, J. A., Li, J., Sassoon, A., Stonhill, M. A., Siegele, B., Liang, X., Dalton, J., Mochel, M. C., Ivashkevich, Y., Johari, V., Sadigh, S., Selove, W., Sood, S., Ward, N., Woda, B., Degar, B., Feraco, A. M., Rowe, J., …, & Tsai, H. K. (2026). Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features. Modern Pathology, 39(7), 101015. https://doi.org/10.1016/j.modpat.2026.101015

Vancouver

Bledsoe JR, Ferry JA, Li J, Sassoon A, Stonhill MA, Siegele B, et al. Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features. Modern Pathology. 2026;39(7):101015. doi:10.1016/j.modpat.2026.101015

BibTeX
@article{Bledsoe2026,
  author = {Bledsoe, Jacob R and Ferry, Judith A and Li, Jingwei and Sassoon, Aaron and Stonhill, Miekan A and Siegele, Bradford and Liang, Xiayuan and Dalton, Justin and Mochel, Mark C and Ivashkevich, Yana and Johari, Vandita and Sadigh, Sam and Selove, William and Sood, Sadhika and Ward, Nicholas and Woda, Bruce and Degar, Barbara and Feraco, Angela M and Rowe, Jared and Davies, Kimberly and Al-Ibraheemi, Alyaa and Amador, Catalina and Kovach, Alexandra E and Fleming, Mark D and Harris, Marian H and Tsai, Harrison K},
  title = {Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {7},
  pages = {101015},
  doi = {10.1016/j.modpat.2026.101015}
}
Kostenlos starten →